CYP24A1 Involvement in Inflammatory Factor Regulation Occurs via the Wnt Signaling Pathway

Abstract

Objective

While the upregulation of cytochrome P450 family 24 subfamily A member 1 (CYP24A1) gene expression has been reported in colon cancer, its role in tumorigenesis remains largely unknown. In this study, we aimed to investigate the involvement of CYP24A1 in Wnt pathway regulation via the nuclear factor kappa B (NF-κB) pathway.

Methods

The human colon cancer cell lines HCT-116 and Caco-2 were subjected to stimulation with interleukin-6 (IL-6) as well as tumor necrosis factor alpha (TNF-α), with subsequent treatment using the NF-κB pathway-specific inhibitor ammonium pyrrolidinedithiocarbamate (PDTC). Furthermore, CYP24A1 expression was subjected to knockdown via the use of small interfering RNA (siRNA). Subsequently, NF-κB pathway activation was determined by an electrophoretic mobility shift assay, and the transcriptional activity of β-catenin was determined by a dual-luciferase reporter assay. A mouse ulcerative colitis (UC)-associated carcinogenesis model was established, wherein TNF-α and the NF-κB pathway were blocked by anti-TNF-α monoclonal antibody and NF-κB antisense oligonucleotides, respectively. Then the tumor size and protein level of CYP24A1 were determined.

Results

IL-6 and TNF-α upregulated CYP24A1 expression and activated the NF-κB pathway in colon cancer cells. PDTC significantly inhibited this increase in CYP24A1 expression. Additionally, knockdown of CYP24A1 expression by siRNA could partially antagonize Wnt pathway activation. Upregulated CYP24A1 expression was observed in the colonic epithelial cells of UC-associated carcinoma mouse models. Anti-TNF-α monoclonal antibody and NF-κB antisense oligonucleotides decreased the tumor size and suppressed CYP24A1 expression.

Conclusion

Taken together, this study suggests that inflammatory factors may increase CYP24A1 expression via NF-κB pathway activation, which in turn stimulates Wnt signaling.

References

[1] Di RosaM, MalaguarneraM, ZanghìA, et al.. Vitamin D3 insufficiency and colorectal cancer. Crit Rev Oncol Hematol, 2013, 88(3): 594-612

[2] FleetJC, DeSmetM, JohnsonR, et al.. Vitamin D and Cancer: A review of molecular mechanisms. Biochem J, 2012, 441(1): 61-76

[3] DussoAS, BrownAJ, SlatopolskyE. Vitamin D. Am J Physiol Renal Physiol, 2005, 289(1): F8-28

[4] GandiniS, BoniolM, HaukkaJ, et al.. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer, 2011, 128(6): 1414-1424

[5] UlitskyA, AnanthakrishnanAN, NaikA, et al.. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN J Parenter Enteral Nutr, 2011, 35(3): 308-316

[6] HummelDM, ThiemU, HobausJ, et al.. Prevention of preneoplastic lesions by dietary vitamin D in a mouse model of colorectal carcinogenesis. J Steroid Biochem Mol Biol, 2013, 136: 284-288

[7] ChenXQ, MaoJY, LiWB, et al.. Association between CYP24A1 polymorphisms and the risk of colonic polyps and colon cancer in a Chinese population. World J Gastroenterol, 2017, 23(28): 5179-5186

[8] FengYJ, WangN, FangLW, et al.. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer. Hum Pathol, 2016, 50: 101-108

[9] HorvathHC, LakatosP, KosaJP, et al.. The Candidate Oncogene CYP24A1: A Potential Biomarker for Colorectal Tumorigenesis. J Histochem Cytochem, 2010, 58(3): 277-285

[10] Noyola-MartínezN, DíazL, Zaga-ClavellinaV, et al.. Regulation of CYP27B1 and CYP24A1 gene expression by recombinant pro-inflammatory cytokines in cultured human trophoblasts. J Steroid Biochem Mol Biol, 2014, 144(A): 106-9

[11] WangL, GaoZ, WangL, et al.. Upregulation of nuclear factor- κ B activity mediates CYP24 expression and reactive oxygen species production in indoxyl sulfate-induced chronic kidney disease. Nephrology (Carlton), 2016, 21: 774-781

[12] LarribaMJ, González-SanchoJM, BarbáchanoA, et al.. Vitamin D is a multilevel repressor of Wnt/b-Catenin signaling in cancer cells. Cancers (Basel), 2013, 5(4): 1242-1260

[13] MaoJ, ChenX, WangC, et al.. Effects and mechanism of the bile acid (farnesoid X) receptor on the Wnt/β-catenin signaling pathway in colon cancer. Oncol Lett, 2020, 20(1): 337-345

[14] GröschelC, TennakoonS, KállayE. Cytochrome P450 Vitamin D Hydroxylases in Inflammation and Cancer. Adv Pharmacol, 2015, 74: 413-58

[15] UllmanTA, ItzkowitzSH. Intestinal inflammation and cancer. Gastroenterology, 2011, 140(6): 1807-1816

[16] Ben-neriahY, KarinM. Inflammation meets cancer, with NF-κB as the matchmaker. Nat Immunol, 2011, 12(8): 715-723

[17] LiY, de HaarC, ChenM, et al.. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis. Gut, 2010, 59(2): 227-235

[18] OshimaH, OshimaM. The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models. J Gastroenterol, 2012, 47(2): 97-106

[19] GrivennikovS, KarinE, TerzicJ, et al.. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell, 2009, 15(2): 103-113

[20] DengL, ZhouJ-F, SellersRS, et al.. A novel mouse model of inflammatory bowel disease links mammalian Target of Rapamycin-Dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis. Am J Pathol, 2010, 176(2): 952-967

[21] KawadaM, SenoH, UenoyamaY, et al.. Signal transducers and activators of transcription 3 activation is involved in nuclear accumulation of beta-catenin in colorectal cancer. Cancer Res, 2006, 66(6): 2913-2917

[22] PopivanovaBK, KitamuraK, WuY, et al.. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest, 2008, 118(2): 560-570

[23] HummelDM, FetahuIS, GröschelC, et al.. Role of proinflammatory cytokines on expression of vitamin D metabolism and target genes in colon cancer cells. J Steroid Biochem Mol Biol, 2014, 144(PtA): 91-95

[24] MuranoM, MaemuraK, HirataI, et al.. Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis. Clin Exp Immunol, 2000, 120(1): 51-58

[25] WangL, WaliaB, EvansJ, et al.. IL-6 induces NF-kappaB activation in the intestinal epithelia. J Immunol, 2003, 171(6): 3194-3201

[26] HeF, PengJ, DengX, et al.. Cytokine mechanisms of tumor necrosis factor-alpha-induced leaks in intestine epithelial barrier. Cytokine, 2012, 59(2): 264-272

[27] TanakaT, KohnoH, SuzukiR, et al.. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci, 2003, 94(11): 965-973

[28] NauglerWE, KarinM. NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev, 2008, 18(1): 19-26

[29] GretenFR, EckmannL, GretenTF, et al.. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell, 2004, 118(3): 285-296